2001
ANNUAL MEETING
CALL
FOR ABSTRACTS
MONTREAL, QUEBEC
June 23-28, 2001
Instructions for all Abstracts
Notification of Programming
Example Formats
Deadlines:
Abstracts
must be submitted by E-mail to abstractinfo@teratology.org
by February 7, 2001.
| Instructions for all Abstracts |
|
All
abstracts are to be sent by E-mail to the following address:
abstractinfo@teratology.org
Note: Abstract submission is separate from registration. Please
visit the Teratology Society Web site (http://teratology.org)
to register and obtain more information about the meeting.
Instructions
for Abstract Submission: This year, abstracts are to be
submitted by E-mail only.* The preferred method is as an attached
document. All major word processors (e.g., Word, WordPerfect,
Word Pro, etc.) are supported.
- Abstracts
should be no more than 1700 characters in length—not
including Title, Authors or Institutions. This limit does
include all text, spaces and punctuation.
-
-
Do
not indent the title. State authors' names using initials
only for first and middle names. Include institution,
city and state/country. Do not abbreviate names of states.
Omit degrees, titles, institutional appointments, street
addresses and zip codes. Underline the abstract title.
(See sample format at end of file.)
-
The
text of the abstract should consist of a single paragraph
and start with a single tab indentation. The abstract
should be factual and informative. It should adequately
summarize the paper to be presented, including results
and conclusions. Do not indicate that "results will be
presented."
-
If
an abstract includes mathematical or structural chemical
formulae, tables, figures or other special layout, the
author must fax a copy to (301) 983-5261 by the deadline
to ensure accuracy of the final abstract. Please include
a phone number and/or E-mail address so that we can contact
the sender if necessary. The committee reserves the right
to change layout or notation that cannot be properly converted
into the format used for final printing.
-
The
use of standard abbreviations is desirable (e.g., rbc,
kg, mg). A special or unusual abbreviation should be placed
in parentheses after the first appearance of the full
word which it represents. Numerals rather than words should
indicate numbers, except to begin sentences.
-
All
abstracts presented at the 2001 Annual Meeting will be
published in TERATOLOGY, the official journal of
the Society. Any abstracts not accepted revert to the
author(s).
-
For
questions or further instructions, send an E-mail message
to abstractinfo@teratology.org or telephone (301) 806-4878.
*If E-mail submission, as explained above, is impossible
for any reason, please call (301) 806-4878 or E-mail abstractinfo@teratology.org.
IMPORTANT
!! Please submit selections for the following 3 items with
the abstract. This information may be included in the word
processing document or in the E-mail message to which it is
an attachment.
8.
Please indicate with a (1) and (2) your first and second choices
for presentation session. Be sure to include this selection
when you send the abstract.
| _______
Clinical Teratology |
_______
In Vitro Studies |
| _______
Developmental Pharmacology |
_______
Mechanisms of Abnormal Development |
| _______
Epidemiology |
_______
Molecular Biology |
| _______
Functional/Postnatal Teratology |
_______
Placental Function/Implantation |
| _______
Genetics and Cytogenetics |
_______
Public Policy |
| _______
Genomics |
_______
Toxicokinetics |
| _______
Hazard/Risk Evaluation |
_______
Other ____________________________ |
9.
Please state one of the following as your preference.
| _______
Paper from platform only (If
your material can be presented only from the platform,
please document in the E-mail message.) |
| _______
Platform or Poster, if not accepted for Platform |
| _______
Poster session only |
10.
State whether you wish to be considered for a Young Investigator
Travel Award and/or for a Best Paper presentation by a pre/post-doctoral
trainee.
If you wish to be considered for either or both awards, you
will need to provide the following:
| 1)
A letter of application from your research supervisor
or program director that contains: |
•
A specific statement to confirm that you are a
student currently enrolled at the sponsoring institution
or that you are a post-doc still in the formal
training phase of your education.
|
•
A brief description of the curriculum of study
and/or your research program.
|
•
An assessment of the qualities that would single
you out for recognition by the Teratology Society.
|
| 2)
One copy of the abstract you submitted for the meeting. |
| 3)
(Optional) Additional introduction, methods,
results, discussion, and/or two pages of illustrative
materials. |
Send
award materials to:
Teratology
Abstract Submissions
8716 Liberty Lane
Potomac, MD
20854-3625,
USA
| Notification
of Programming |
|
If the abstract is accepted for presentation at the 2001 Annual
Meeting, the first author will be notified by E-mail by April
3, 2001, concerning the following:
Title of session for abstract presentation
Date and time of session
Format of presentation (oral or poster)
DEADLINE: February 7, 2001
For Program information, contact Jan Friedman, Vice President,
at 770-488-7291.
FORMAT
FOR ONE AUTHOR
DIEHL, S.R., Craniofacial Epidemiology and Genetics Branch,
NIDCR, NIH, Bethesda, Maryland. Insights from genome scans
versus candidate gene polymorphisms for understanding the
etiology of teratogen-induced oral clefts in mouse and man.
Studies in mouse and man have shown that non-syndromic oral
clefts have a complex etiology. Large differences among mouse
lines for spontaneous and...
FORMAT FOR MULTIPLE AUTHORS FROM SAME AFFILIATION
COLLINS,
M.D., G.S. LEE, R.M. CANTOR and D.N. HOVLAND, JR., UCLA, Los
Angeles, California. Whole genome scan to identify chromosomal
loci associated with a strain difference in susceptibility
to cadmium-induced forelimb defects.
Although numerous murine strain differences in response to
teratogenic treatment have been documented...
FORMAT FOR MULTIPLE AUTHORS WITH DIFFERENT AFFILIATIONS
ORUP1,
Jr., H.I., B.A. COULL2, J. ADAMS3, L.M.
RYAN2 and L.B. HOLMES1. 1Genetics
and Teratology Unit, Pediatric Service, Massachusetts General
Hospital;
2Department of Biostatistics, Harvard School of
Public Health; and 3Department of Psychology, University
of Massachusetts, Boston, Massachusetts. Changes in craniofacial
features in children exposed to antiepileptic drugs in utero.
Sixty-six children age 6.5 years and older have been evaluated
for: 1) changes in skull morphology and...
Meetings
format